The global Chronic Kidney Disease Diagnostics Market is expanding steadily due to the increasing prevalence of kidney disorders and growing demand for early disease detection. The market was valued at approximately USD 7.9 billion in 2023 and is projected to reach USD 15.6 billion by 2032, registering a compound annual growth rate (CAGR) of 7.9% between 2024 and 2032.
Rising incidence of diabetes and hypertension—two primary risk factors for kidney disease—continues to fuel the Chronic Kidney Disease Diagnostics Market. According to global health statistics, more than 850 million people worldwide suffer from kidney diseases, while chronic kidney disease affects nearly 10% of the global population.
Historical Growth of the Chronic Kidney Disease Diagnostics Market (2015–2024)
The Chronic Kidney Disease Diagnostics Market has demonstrated steady growth over the past decade as healthcare systems prioritize early detection and disease management.
Historical market figures highlight consistent expansion:
Between 2015 and 2024, the Chronic Kidney Disease Diagnostics Market expanded by over 107%, reflecting rising diagnostic demand worldwide.
Year-over-year comparisons show sustained growth momentum:
These figures demonstrate increasing clinical adoption of kidney disease screening tests.
Rising CKD Prevalence Driving Diagnostic Demand
The growing global burden of kidney disease is a key driver of the Chronic Kidney Disease Diagnostics Market.
Important statistics include:
-
850 million people globally affected by kidney diseases
-
37 million adults in the United States diagnosed with CKD
-
13% of adults worldwide estimated to have early-stage CKD
Early diagnosis significantly improves treatment outcomes. Studies indicate that timely CKD detection can reduce disease progression risk by up to 45%, increasing demand for routine diagnostic screening.
The number of kidney function tests conducted worldwide surpassed 1.4 billion tests in 2023, representing 8.2% growth compared to 2022.
Growth in Diagnostic Testing Technologies
Technological advancements are expanding the Chronic Kidney Disease Diagnostics Market.
Common diagnostic tests include:
Global diagnostic laboratory statistics show:
-
Over 2.6 billion blood chemistry tests performed annually
-
Urine protein tests increased by 9.3% between 2021 and 2024
-
Point-of-care diagnostic devices adoption rose by 18% worldwide
Advanced biomarkers and AI-based diagnostic tools are also improving disease detection accuracy by over 20% compared to conventional methods.
Regional Breakdown of the Chronic Kidney Disease Diagnostics Market
North America Leading Global Market
North America accounted for approximately 38% of the global Chronic Kidney Disease Diagnostics Market in 2023.
Key regional data includes:
-
The United States recorded 785,000 patients with kidney failure
-
Annual healthcare spending on kidney disease exceeded USD 130 billion
-
Over 400 million diagnostic tests related to kidney health are conducted annually
Strong healthcare infrastructure and widespread screening programs continue to drive market dominance.
Europe Maintaining Strong Market Presence
Europe represents about 30% of the global Chronic Kidney Disease Diagnostics Market.
Important statistics include:
-
More than 100 million Europeans suffer from CKD
-
European healthcare systems conduct 350 million kidney-related diagnostic tests annually
-
Healthcare spending on kidney disease increased 11% between 2020 and 2023
Countries such as Germany, France, and the United Kingdom are major contributors to regional diagnostic demand.
Asia-Pacific Emerging as High-Growth Region
Asia-Pacific is projected to be the fastest-growing region in the Chronic Kidney Disease Diagnostics Market, with a CAGR of 9.1% through 2032.
Regional statistics show:
-
China has over 120 million CKD patients
-
India records approximately 220,000 new kidney failure cases annually
-
Japan conducts over 150 million kidney screening tests each year
Rapid healthcare infrastructure expansion and government screening programs are driving regional growth.
Industry and Company Statistics
The Chronic Kidney Disease Diagnostics Market includes global diagnostic companies and laboratory service providers.
Industry insights include:
-
The top 12 diagnostic companies account for nearly 60% of global market revenue
-
Clinical laboratories perform over 500 million kidney function tests annually
-
Diagnostic device manufacturers increased R&D spending by 14.7% between 2021 and 2024
Additionally, the global in-vitro diagnostics industry exceeded USD 92 billion in revenue in 2023, supporting innovation in kidney disease testing technologies.
Government Programs and Healthcare Investments
Government initiatives play a significant role in expanding the Chronic Kidney Disease Diagnostics Market.
Key healthcare investments include:
-
The United States allocated USD 25 billion for kidney disease treatment and prevention programs
-
The European Union invested EUR 3.2 billion in chronic disease diagnostic research
-
China increased funding for kidney disease screening programs by 18% in 2023
Public health programs focusing on diabetes and hypertension screening are also increasing kidney disease detection rates.
Global healthcare spending on chronic disease diagnostics increased 9.4% in 2023, supporting market expansion.
Future Forecast of the Chronic Kidney Disease Diagnostics Market (2025–2032)
The Chronic Kidney Disease Diagnostics Market is expected to experience steady growth over the next decade.
Projected market values include:
-
2025: USD 9.2 billion
-
2027: USD 10.9 billion
-
2029: USD 12.8 billion
-
2032: USD 15.6 billion
Several factors will drive market expansion:
-
Rising global prevalence of diabetes and hypertension
-
Increased adoption of early diagnostic screening
-
Advancements in biomarker-based testing technologies
-
Expanding healthcare infrastructure in emerging economies
Point-of-care diagnostic devices for kidney disease are expected to grow at 11.5% CAGR through 2032, reflecting increased demand for rapid testing.
Clinical Research and Diagnostic Adoption Trends
Research in kidney disease diagnostics continues to grow.
Key research statistics include:
-
Over 900 clinical studies related to kidney biomarkers conducted globally in 2024
-
65% of hospitals worldwide now include routine CKD screening for high-risk patients
-
Diagnostic accuracy rates for advanced kidney biomarkers exceed 93%
Recent healthcare surveys show that:
These trends are accelerating the expansion of the Chronic Kidney Disease Diagnostics Market.
Data-Driven Market Outlook
The Chronic Kidney Disease Diagnostics Market is becoming increasingly critical as kidney disease prevalence rises worldwide. Increasing healthcare investments, technological advancements in diagnostics, and growing awareness of early disease detection are driving strong market growth.
Global market revenues increased from USD 4.1 billion in 2015 to approximately USD 8.5 billion in 2024, reflecting sustained expansion.
By 2032, the Chronic Kidney Disease Diagnostics Market is projected to exceed USD 15.6 billion, supported by 7.9% CAGR, expanding diagnostic infrastructure, and growing chronic disease screening programs.
As healthcare systems prioritize early detection and preventive care, the Chronic Kidney Disease Diagnostics Market will remain a vital component of global healthcare diagnostics.
Read Full Research Study: https://marketintelo.com/report/chronic-kidney-disease-diagnostics-market
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
